We are a venture holding company that turns overlooked science into outsized returns
We create and combine breakthrough IP with overlooked assets to deliver rapid, venture returns at private equity risk

FVE FUNDS

FVE funds invest in great life science companies, including Foundry spinouts, helping them launch and grow

Set ventures up for success by assisting with stage-agnostic funding, non-dilutive funding, licensing, patent filing, and team building.

Through the Foundry, we de-risk the technology and the market before we build
Validate the technology before company formation
We run low-capital experiments to pressure-test the IP. Expert reviews, targeted experiments, and real-world validation ensures we only build around what works, not just what looks promising.
Work backward from market demand
We engage potential acquirers early to align on unmet needs. This helps us shape companies with real buy-side interest—maximizing the chance that our science makes it to patients, not purgatory.
The Collaboratory
We’ve partnered with labs and institutions that offer best-in-class capabilities and flexibility
World-leading postdoc research firms
Research partners in precision medicine with best-in-class analytics and
bioinformatics tools
Clinical trial experts with agile collaboration models
Low-cost CROs for small-molecule discovery & rapid deal sourcing
TimeX Capital powers our capital strategy, deal execution, and exits
125+
IPOs including Alibaba
Multiple hundred million M&A deals
Decades of experience with IPO, fundraising and M&A
Experts across healthcare, tech and sustainable infra
Let’s have a conversation
Contact us